Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma-Reference-Cited by-同舟云学术

Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma

Published:2022-01 Issue:1 Volume:17 Page:89-102
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Gross Daniel J.,Chintala Navin K.,Vaghjiani Raj G.,Grosser Rachel,Tan Kay See,Li Xiaoyu,Choe Jennie,Li Yan,Aly Rania G.,Emoto Katsura,Zheng Hua,Dux Joseph,Cheema Waseem,Bott Matthew J.,Travis William D.,Isbell James M.,Li Bob T.,Jones David R.,Adusumilli Prasad S.

Funder

National Institutes of Health

US Department of Defense

Thoracic Surgery Foundation

Memorial Sloan Kettering Cancer Center Fiona and Stanley Druckenmiller Center for Lung Cancer Research

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference49 articles.

1. Predictive value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival;Hung;J Clin Oncol,2014

2. Solid predominant histologic subtype in resected stage I lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor postrecurrence survival;Ujiie;J Clin Oncol,2015